Stryker Corporation

New York Stock Exchange
Back to all articles
Bullish +75

Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting - PR Newswire

🦴 Stryker launches Triathlon Gold, the first commercially available femoral component using additive manufacturing and Titanium nitride coating to address metal sensitivity concerns.

🤖 Mako Shoulder enters full market release, integrating Tornier Perform Reversed implants and Blueprint planning software to simplify reverse shoulder surgery.

🔧 Mako RPS (Robotic Power System) is introduced for Total Knee, combining proven robotics with a handheld design familiar to surgeons using manual power tools.

⚡ New power tool portfolio includes the BPX cordless micro system for extremities and the TPX HD solution built for total joint revisions and trauma surgeries.

📅 Mako Shoulder will be available on the Mako 4 platform starting in the second half of 2026.

👩‍⚕️ Lisa Kloes, VP of Stryker's Knee business, states the new Triathlon solutions are shaped by customer insight to meet evolving patient needs.

🏥 Katherine Truppi, President of Joint Replacement division, notes these innovations help patients return to activities they love as the industry evolves.

📍 Innovations were showcased at the AAOS 2026 Annual Meeting in New Orleans with demonstrations and symposiums held throughout the week.

🔬 Triathlon Gold features a cementless technology designed for fixation and long-term durability with scratch resistance superior to competitive surfaces.

🦵 The Triathlon Medial Stabilized (MS) Insert provides enhanced stability for primary knee patients while allowing more natural rotational kinematics.

Bullish Signals
  • Triathlon Gold introduces a novel additive manufacturing process and Titanium nitride coating specifically designed to solve metal sensitivity concerns, expanding patient eligibility.
  • The new Triathlon Medial Stabilized (MS) Insert leverages existing Mako SmartRobotics technology to provide enhanced stability and natural rotational kinematics for primary knee patients.
  • Mako Shoulder is now in full market release, offering a comprehensive connected solution that simplifies complex reverse shoulder surgery tasks and increases surgeon confidence.
  • Mako RPS bridges the gap between manual power tool familiarity and robotic advantages, targeting a specific subset of surgeons looking for hybrid capabilities.
  • The TPX HD power tool system is explicitly built for demanding procedures like total joint revisions and trauma, featuring enhanced power and specialized attachments capable of cutting through metal and bone cement.
  • Stryker's commitment to innovation across orthopaedic specialties reinforces its position as a global leader with over 20 years of proven outcomes in the Triathlon system.
Full Analysis
Stryker (NYSE: SYK) unveiled a suite of new orthopaedic innovations at the AAOS 2026 Annual Meeting in New Orleans, reinforcing its commitment to advancing care across multiple specialties. Key highlights include the commercial launch of Triathlon Gold, the first femoral component utilizing additive manufacturing and Titanium nitride coating to address metal sensitivity while offering superior scratch resistance and durability. The company also expanded its Mako SmartRobotics portfolio with the full market release of Mako Shoulder for reverse shoulder surgery and the introduction of Mako RPS, a handheld robotic system compatible with the Triathlon Total Knee System. Additionally, Stryker launched new power tool systems, including the BPX cordless micro tool for extremities and the TPX HD solution designed for complex total joint revisions and trauma procedures. Executives Lisa Kloes and Katherine Truppi emphasized that these developments represent the next evolution of Stryker's legacy products, driven by customer insights to meet evolving patient needs. The new offerings aim to simplify complex clinical tasks, enhance stability for primary knee patients, and provide surgeons with flexible options ranging from manual workflows to advanced robotic assistance. These product launches were showcased alongside demonstrations and symposiums at the AAOS event, where attendees could view the innovations at Stryker's booth. The company highlighted its global impact on over 150 million patients annually through its MedSurg, Neurotechnology, and Orthopaedics divisions, positioning these new tools as critical for improving patient outcomes and returning them to active lifestyles.